Background illustration for clinical trials search

Alzheimer's Disease Clinical Trials

Browse 585 Alzheimer's Disease clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Cognitive-Function Informed Outpatient Child and Youth Mental Healthcare

for
Mental Health Care, Mental Health in Elementary School Children,
Location: Ottawa
Sponsor: Children's Hospital of Eastern Ontario

Sex: All

Age: 7 - 17

Code: NCT07842952

Recruiting

Ask Questions About Clinical Trials

for
Oncology, Cardiac Disease, Neurologic Disorder
Location: Port Huron MI, Mount Clemens MI, Lapeer MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT07343297

Recruiting

Improving Patient Mental Health With Psychotherapist Virtual Training

for
Mental Disorders
Location: Ottawa
Sponsor: University of Ottawa

Sex: All

Age: 18+

Code: NCT07087730

Recruiting

The Canadian Armed Forces PEER Study

for
Depression, Non-psychotic Diagnosis as Co-morbidity
Location: Ottawa
Sponsor: MYnd Analytics

Sex: All

Age: 18 - 65

Code: NCT03625271

Recruiting

Product Surveillance Registry

for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Boston MA, Riverhead NY, Hartford CT, Holyoke MA,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT01524276

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

What is Alzheimer's disease, and why research matters

Alzheimer's begins in the brain 15 to 20 years before the first symptom. Two proteins build up: amyloid, which forms plaques between brain cells, and tau, which forms tangles inside them. Over time nerve cells die, starting in the memory centers. The first stage most people notice is mild cognitive impairment, forgetfulness that is more than normal aging but does not yet disrupt daily life. From there the disease moves through mild, moderate, and severe dementia. Alzheimer's is not a normal part of aging.

Two new drugs, lecanemab and donanemab, can clear the sticky protein (amyloid) from the brain and slowed memory loss by about a third in people caught early. In 2025 doctors got a blood test that finds amyloid, so people no longer need a brain scan or spinal tap to check. Now researchers are trying to treat people who have amyloid but no symptoms yet, hoping to stop the disease before it starts.

Article preview image

Interested in learning more about Alzheimer’s treatment? Read our guide: Alzheimer's Treatment: What's Approved and What's in Trials

What Alzheimer's Treatment Looks Like Today, and Why Timing Matters So Much

Types of Alzheimer's disease clinical trials

What is the difference between Alzheimer's and dementia?

Who can participate in Alzheimer's clinical trials?

The stages of Alzheimer's, and why they matter for trials

How to enroll in an Alzheimer's clinical trial